ARCHIVES

Study Finds Trial Results Reliable At Three Years

This article is from The Cancer Letter archive.

Vol. 28 No. 7 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

Abstracts Of Papers From Gynecologic Oncology Conference

October 17, 1975

NCAB Approves Bypass Budget f $1.685 Billion for FY ’88, $200 Million More Than Asked For ‘87

May 30, 1986

NCI Continues Making Improvements In Contract Management

May 22, 1981

New Treatments And Quality of Life Study For Ovarian Cancer Described At SGO

March 26, 2004

Center Program Move Definite; DCBD to Be Renamed

September 22, 1989